Hugh Alexander Ilyine
Fondatore presso Profactor Pharma Ltd.
Profilo
Hugh Alexander Ilyine is the founder of two companies.
He founded Profactor Pharma Ltd.
in 2009 and Destina Genomics Ltd.
in 2011, where he holds the title of Director and Chief Executive Officer & Executive Director, respectively.
Mr. Ilyine's former jobs include Chief Operating Officer positions at Sierra Leone Diamond Co. Ltd.
and Stem Cell Sciences Plc.
Posizioni attive di Hugh Alexander Ilyine
| Società | Posizione | Inizio |
|---|---|---|
Profactor Pharma Ltd.
 Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Fondatore | 01/01/2009 |
Destina Genomics Ltd.
 Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Fondatore | 01/01/2011 |
Precedenti posizioni note di Hugh Alexander Ilyine
| Società | Posizione | Fine |
|---|---|---|
| Stem Cell Sciences Plc | Direttore operativo | 07/04/2009 |
| Sierra Leone Diamond Co. Ltd. | Direttore operativo | 17/08/2007 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
| Sierra Leone Diamond Co. Ltd. | Non-Energy Minerals |
| Stem Cell Sciences Plc | Commercial Services |
Profactor Pharma Ltd.
Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Health Technology |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Hugh Alexander Ilyine
